Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: CSE: $PVOT.C, CSE: $VGW.C, TSX: $WEED.TO, NYSE: $CGC, CSE: $THC.C
Investor Ideas Potcasts Reporting from MJBizCon - CLS Holdings USA, Inc. (OTCQB: $CLSH) Showcasing at MJBizCon
Delta, Kelowna, BC - November 14, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Cannabis Life Sciences a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries will be showcasing at MJBizCon this week in Las Vegas from November 14-16th.
Day one - Investorideas.com at MJBizCon this week at Podcast Row interviewing industry leaders and experts.
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts. This podcast is sponsored by CLS Holdings USA, Inc. (OTCQB: CLSH).
Pivot Pharmaceuticals Inc. announced that it has placed a Purchase Order with its German manufacturing partner, Solmic GmbH, for 15,000 bottles of Pivot Naturals Oral 1% CBD Solution. The product will be distributed in the European Union to over 1,800 retail and online clients by Pivot's distribution partner, S.T.U. GmbH. The 30 ml bottle will retail for CHF(Swiss Francs) 90.00 and be available for purchase in December 2018. The product is registered in Germany and has the required Pharmazentralnummer (PZN) code. Once a product is introduced in the IFA database, a Pharmazentralnummer (PZN) is assigned. It is the national standard identification code for products in the pharmacy market in Germany and makes the products eligible for sale in other EU countries.
Dr. Patrick Frankham, Pivot's CEO, stated, "With this initial Purchase Order from Europe, Pivot has completed another important milestone. In one year, the Company has successfully transitioned from acquiring patented formulation and delivery technologies to commercializing our catalogue of differentiated bio-cannabis products and initiating sales. Cannabis is an entirely new market and we are paving the way for premium science-based products consumers will demand. With recently announced sales channels and joint venture partners in Latin America, Europe and Canada, across pharmaceutical and beverage markets, Pivot is well positioned to rapidly capture global market share in the emerging industry."
Valens GroWorks Corp., a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced that it has entered into a multi-year Extraction Services Agreement with Harvest One (TSXV:HVT) for cannabis extraction and value-added services.
Under the terms of the Agreement, Harvest One's subsidiary, United Greeneries, will ship bulk quantities of dried cannabis to Valens over an initial three-year term. The Company will receive and process the cannabis on a fee for service basis into bulk resin or other cannabis oil derivative products.
The Company will also conduct R&D services for Harvest One to support their product line development including health and wellness products, beverages, vape pens, and nutraceuticals using cannabis oil derivative products. The significance of these products is reflected in the more developed markets in the United States where raw flower makes up less than half of the products sold.
Canopy Growth Corporation today released its consolidated financial results for the second quarter fiscal 2019 ended September 30, 2018.
During the quarter, Canopy Growth secured capital via a strategic $5 billion investment from Fortune 500 beverage leader Constellation Brands, which closed subsequent to the quarter. These funds will be deployed towards the Company's core strategic objectives of (i) intellectual property development, and (ii) replicating the Company's Canadian platform for success across a large number of international markets. These objectives will be achieved through international acquisitions as well as continued internal investments across the globe, and are discussed in further detail below.
Sales in the second quarter were in line with management's expectations leading into the opening of the recreational cannabis market. Revenue for the second quarter fiscal 2019 was $23.3 million, representing an increase of 33% over the prior year's quarter in which revenue was $17.6 million. As planned, the Company made only limited "test" shipments of $0.7 million into recreational channels during the second quarter to confirm supply chain systems functionality before the launch of recreational cannabis on October 17.
Oils, including the Company's Softgel capsules, accounted for 34% and 18%, in the respective second quarters of fiscal 2019 and 2018, of the product revenue for each period, demonstrating an increased demand for value-added products that require lower active ingredient inputs and provide higher margins.
"With extensive investments over the past year, including most notably in the second quarter, in branding and retail development, our entrance into the retail cannabis market has been a success with our SKU assortment obtaining over 30% listings market share in multi-store physical retail store networks nationwide. With substantial product inventories on hand, new product formats coming to market as planned, a captive sales force driving increased demand through physical retail stores and increasing internal and channel efficiencies, we believe based on market conditions today that we will attain significant and sustainable market share of the Canadian recreational market," Bruce Linton, Chairman & Co-CEO, Canopy Growth.
THC BioMed Intl Ltd. announced that it has received a Cannabis Act and Cannabis Regulations License from Health Canada on November 8, 2018. This is the new license under the Cannabis Act and it allows THC to grow, produce and sell cannabis products on a large scale under the new regime.
THC also announced that Clone Shipper, its wholly-owned subsidiary, has received a Notice of Allowance from the U.S. Patent and Trademark Office regarding THC's patent application for the invention of an illuminated shipping container for live cannabis plants. THC now has three months to conduct a final review of its patent application, file any necessary amendments, submit the formal drawings and pay the Issue fee. The Notice of Allowance is not a grant of patent rights but a notice from the Examiner that the Application is being allowed.
In addition, due to the high demand for our cannabis products, THC has completed its fourth (4th) shipment of cannabis products to the Province of B.C. Its previous three shipments have sold out since launch day on October 17, 2018.
THC is focused on meeting the high demand for its products. It continues to expand and develop its production space, as announced in previous press releases on October 16, 2018, June 29, 2018, June 12, 2018 and earlier.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Point Roberts, WA - November 14, 2018 (Investorideas.com Newswire) cannabis / beverage news - Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the recent JV's (joint ventures) and investments in the cannabis infused beverage market.
Why the urgency to invest and partner in the space? Multiple sources including Business Insider quoted recent market projections from Canaccord Genuity reporting," Marijuana-infused beverages could become a $600 million market in the US in the next four years and big beverage makers are looking to take advantage of that opportunity."
"Revenue from cannabis beverages could outpace the general demand for cannabis products by over two times, capturing 20% of the market for marijuana edibles by 2022, according to the analysts."
Most recent JV news hitting the sector; Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) just announced that it has entered into a letter of intent with Global Canna Labs Limited, the Caribbean's largest medical cannabis producer, to establish a joint venture for the purpose of developing, producing, distributing, marketing and selling cannabis infused beverages, edibles and topical products derived from Sproutly's fully licensed, APP Technology.
From the news: "Partnering with Global Canna Labs on this joint venture allows Sproutly to expand its business outside of Canada with a leading, low cost cannabis cultivator in Jamaica that has proven distribution in across the Caribbean and expanding into the European Union," said Keith Dolo, Chief Executive Officer and Director of Sproutly. "This partnership will enable Sproutly to diversify its product portfolio and accelerate its global distribution network from a low-cost regulated jurisdiction."
Continued: "Paul Glavine, Chief Executive Officer of Global Canna Labs said, "We are eager to roll out this partnership with Sproutly on their APP technology. We have explored a number of options regarding extraction and cannabis technology solutions for beverage and derivative products - APP Technology is in our view the superior choice for beverage formulations. With our current supply and expansion plans to over 1 million square feet of cultivation, we see this partnership with Sproutly as a step towards utilization of our large-scale production towards a finished-product strategy."
In early October, a substantial JV cannabis beverage announcement came from Molson Coors Canada (MCC), the Canadian business unit of Molson Coors Brewing Company, and HEXO Corp. (TSX: HEXO) (OTC:HYYDF). They reported the formation of a joint venture to pursue opportunities to develop non-alcoholic, cannabis-infused beverages for the Canadian market following legalization.
The joint venture, Truss, is led by former Molson Coors executive, Brett Vye, in the role of Chief Executive Officer. Vye reports to the Truss board of directors consisting of three members appointed by MCC and two members appointed by HEXO.
Mark Hunter, President and CEO of Molson Coors was quoted in an article earlier this month saying "clearly there are lots of numbers being bandied around with regard to the potential size of the cannabis market in Canada." He went on to say, "I think, if you take the average, then it suggests that the market may be somewhere between $7 billion and $10 billion in market value, with beverages somewhere between 20% and 30%, and that's obviously non-alcoholic cannabis infused beverages. Even if you take the low end of that estimate, then it suggests that the beverages segment could be circa $1.5 billion of value. We're well placed to take a meaningful share of that segment."
Not only are many companies looking to be the first to the beverage market, whether locally or internationally, but the consumer demand seems to be pushing that direction as well.
According to one survey, "76% of US and Canadian's surveyed said they would use legal cannabis-infused products for therapeutic reasons, with nearly a quarter indicating that they'd try recreational cannabis via skincare products like lotions, creams and lip balms. 41% of the participants said they'd be more likely to try recreational cannabis through food, slightly higher than the 39% of those surveyed who said they would smoke it."
There has been heavy investment into this concept, the largest example being the $5 Billion CAD [$4 Billion USD] investment from Constellation Brands into Canopy Growth Corp. (NYSE:CGC) (TSX:WEED), though speculation continues around Coca Cola's interest in the Cannabis sector.
In a recent CBC article, Bruce Linton, the founder and co-CEO of Canopy Growth said "new products developed by Tweed represent the next big opportunity."
Continued: "I think if you're not preparing things two years in advance, you're never ready," he said. "Right now, none of the chocolate or gummy bears or beverages can be prepared or sold, but we're doing experiments on how to make them."
Walmart, much like Coca Cola, according New Frontier Data "has also led some investigation into the cannabis market for although Walmart does not sell CBD products, it does sell a variety of hemp-derived products; such as hemp oil, hemp soap, and hemp fiber."
Continued: "At present, none of these large hemp companies sell CBD-related products, but look for some of them to start in 2019 as several leading brands look to expand their product offering into hemp-derived CBD to capitalize on mass market distribution opportunities. For now, all eyes are on the Farm Bill and FDA to give mass markets retailers, like Walmart, the green light to begin selling hemp products with CBD."
As countries race to allow new legalization for cannabis, companies in the sector continue to push to be leading innovators. The next year offers the potential passing of the 2018 Farm Bill as well as the legalization of edibles and beverages in Canada on October 2019, which could see consumers very close to their first ‘cannabeverage'.
Investors can expect to see more money flow and JV's as the sector ramps up.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring Sproutly (SPR: CSE / SRUTF: OTCQB) is a paid for article at Investorideas.com - learn more about costs and services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $CRON.TO, TSXV: $FIRE.V, CSE: $GGB.C, CSE: $ASNT.C, CSE: $MTEC.C
Delta, Kelowna, BC - November 13, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Cannabis Life Sciences a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries will be showcasing at MJBizCon this week in Las Vegas from November 14-16th.
Investorideas.com will be at MJBizCon this week at Podcasters Row interviewing industry leaders and experts.
Good morning and welcome to today's edition of Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts, brought to you with this month's content partner, CLS Holdings USA, Inc. (OTCQB: CLSH).
Today we will be looking at announcements from Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON), The Supreme Cannabis Company, Inc. (TSXV: FIRE), Xanthic Biopharma Inc. d.b.a. Green Growth Brands (CSE:GGB), Ascent Industries Corp. (CSE: ASNT) and Cannvas MedTech Inc. (CSE: MTEC)
"We are encouraged with our third quarter results, which reflect the meaningful progress we are making on our strategic initiatives. In the quarter, we announced a number of landmark partnerships to expand our reach beyond the flower and beyond Canada and launched our second differentiated recreational cannabis brand," said Mike Gorenstein, CEO of Cronos Group. "The recent legalization of cannabis sales for adult recreational use in Canada was a watershed moment for our industry and our Company. We are energized by the opportunities this creates for Cronos Group in Canada and look forward to leading the industry forward responsibly."
"As excited as we are about this milestone and our participation in this new market, it's truly just the beginning. Cronos Group is building an innovative global cannabinoid company. The opportunities for our Company extend across the globe as regulations evolve and markets open. The recent initiatives we launched with Gingko Bioworks and Technion are great examples of how we intend to use innovation and our growing intellectual property portfolio to develop new applications for cannabinoids across a range of categories. We are proud of all that we accomplished this quarter, and we are focused on executing on our strategic plan to drive growth and value creation for our shareholders, partners and consumers," concluded Mike Gorenstein.
Highlights from the third quarter 2018 included revenues which totaled $3.8 million, as compared to $1.3 million for the third quarter of 2017, representing an increase of $2.4 million, or 186%. Kilograms of cannabis sold increased 213% in the third quarter from 164 kilograms in the third quarter of 2017 to 514 kilograms in the third quarter of 2018. The main drivers associated with the increase in revenues and the increase in kilograms sold are increased production capacity and increased volumes sold through the domestic medical and international channels, as well as initial shipments into the domestic adult-use recreational market.
The Company also continues to see strong growth in cannabis oil sales, which represented 29% of total revenue in the third quarter of 2018.
The Supreme Cannabis Company, Inc. announced today that it has entered into a definitive agreement to acquire leading communications and stakeholder relations firm Bayfield Strategy, Inc. Bayfield's CEO, founder and shareholder, Riyaz Lalani, will be appointed to the position of Chief Corporate Officer of the Company where he will help shepherd the Company through its next stage of growth as a leading premium cannabis producer in the world. Bayfield's employees will enter into employment agreements with Supreme Cannabis and assume a variety of roles in corporate operations and stakeholder relations.
Over the last two decades, Mr. Lalani has advised public companies, boards of directors, private equity funds and hedge funds across North America. Prior to founding Bayfield, Mr. Lalani was the Chief Operating Officer of the leading shareholder services firm in Canada. Beforehand he was the head of research for an international asset manager in New York and Toronto, focused on investments in biotechnology, life sciences, resources, and a variety of other industry sectors. Mr. Lalani will contribute a unique and diverse experience set that encompasses capital allocation, strategic communications, and operational execution.
Xanthic Biopharma Inc. d.b.a. Green Growth Brands made its trading debut on the Canadian Securities Exchange (CSE) at today's market open under the ticker symbol "GGB". The highly-anticipated listing on the CSE represents the completion of the reverse takeover (RTO) announced by the Company in July 2018.
"Our listing on the Canadian Securities Exchange represents a significant milestone in the journey of building Green Growth Brands," said Peter Horvath, CEO of GGB's operating entity. "The transition to a publicly-traded company will benefit our current investors, give new investors a chance to join us and provide the Company with the currency to facilitate our aggressive growth plan."
"Our team has run multi-billion dollar businesses, operating as number ones in their respective categories, competing for customers in saturated mature markets. We're eager to do it again in the burgeoning North American cannabis industry," continued Horvath.
Ascent Industries Corp., through its wholly owned subsidiary, Thirty Eight Hemp Corp., continues to prepare for an emerging hemp and CBD market. The regulatory regime in the United States relating to CBD is undergoing a significant transformation and the Company believes that the recent mid-term elections in the United States were a positive indication of this. The movement towards the removal of hemp (cannabis with less than 0.3% THC content) from Schedule I of the United States Controlled Substances Act ("CSA") is gaining momentum. When the United States Hemp Farming Act of 2018 (the "Hemp Farming Act") is enacted, hemp is expected to be fully de-scheduled from the CSA, making it an ordinary agricultural commodity and providing a significant market opportunity for hemp derived products.
Through its unique strategic relationship with AgTech Scientific Inc. of Paris, Kentucky, the Company plans to exploit the opportunity expected in the hemp markets to significantly expand its distribution of CBD-based products throughout the United States and internationally.
Ascent's Chief Operating Officer, Reid Parr commented, "The are many reasons for this strategic relationship, but the main reason is that compared to their competitors, AgTech has true vertical integration. They have world class genetics, large scale farming including outdoor and indoor high-tech greenhouses as well as large scale, GMP compliant, state of the art extraction and product manufacturing."
"We are building MM Patient Relief to be the most physician centric, data driven licensed producer to meet the needs of sophisticated clients who are looking for an effective alternative to pharmaceuticals," said Alex Ciotoli, President, Medical Marihuana Patient Relief Inc. "Working with Cannvas enables us to have the latest education content which is a core component to meeting our objectives."
This podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) - more info and details can be found at our disclaimer and disclosure page at Investorideas.com
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
